Abdominal tumours and neurofibromatosis.

A. Martin,R. Williamson

DOI: https://doi.org/10.1136/pgmj.72.843.59

1996-01-01

Postgraduate Medical Journal

Abstract:Accepted 1 June 1995 A 50-year-old, black female nurse was found to be hepatitis B positive in a routine screen. She was entirely asymptomatic and had never been jaundiced. Liver function tests were normal, but an ultrasound scan showed dilatation of the bile duct plus a cystic lesion near the pancreatic tail. Duodenoscopy revealed a small tumour at the ampulla of Vater, and biopsy showed 'adenocarcinoma with areas of carcinoid differentiation'. The patient had Type 1 neurofibromatosis and three years earlier had developed mild hypertension with several episodes of paroxysmal headache. A series of urinary vanillyl mandelic acid levels had been normal at that time, and the hypertension was well controlled with a beta-blocker. Physical examination was unremarkable apart from the iris hamartomas ('Lisch nodules') and cutaneous neurofibromas typical ofType 1 neurofibromatosis. A gastrointestinal hormone screen showed a minimally increased plasma somatostatin level of 171 pmol/l (upper limit ofnormal (uln) 150), but an oral glucose tolerance test was normal. Urinary catecholamine levels were slightly raised but not diagnostic of phaeochromocytoma: noradrenalin 0.85 11mol/24 h (uln 0.59), adrenalin 0.75 ftmol/24 h (uln 0.19), dopamine 2.1 pmol/24 h (uln 3.27). Abdominal computed tomography (CT) was performed (figure).